November marks both National Caregivers and Alzheimer’s Awareness months, recognizing those with Alzheimer’s disease (AD) and their families and caregivers who play a significant role caring for people with this progressive brain disease. SYNAPS Dx (SDx) honors those experiencing AD and the people who care for them not only during November, but also throughout the entire year. In the …
SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), is pleased to announce the publication of “Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients” in Scientific Reports. “Up until now, there have been no autopsy-validated tests shown to accurately …
Input your search keywords and press Enter.
Recent Comments